Massachusetts-based Mersana shared initial phase 1 data on Emi-Le, an antibody-drug conjugate (ADC) that targets B7-H4, in January. The biotech is now running the expansion portion of the study in ...

Last week’s breakdown below the 100-period SMA on the H4 warrants caution for bulls. Bears might now wait for weakness below the 1.1265 region before placing fresh bets. The EUR/USD pair ...